Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]ga-Psma-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer.
EUROPEAN UROLOGY ONCOLOGY（2024）
关键词
Clinically significant prostate cancer,Diagnosis,Multiparametric magnetic resonance imaging,Prostate cancer,Prostate-specific membrane antigen,Positron emission tomography scan
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要